French insurtech Alan raises €480 million to challenge Canada's group benefits incumbents

Alan triples Canadian membership and raises €480 million as it targets Sun Life, Manulife and Great-West Life

French insurtech Alan raises €480 million to challenge Canada's group benefits incumbents

Insurance News

By Josh Recamara

French digital health insurer Alan has agreed a €480 million ($550 million) Series G funding round valuing the company at €5.5 billion ($6.3 billion), with Canada identified as the primary growth market for the fresh capital.

The round is led by Prosus, one of the world's largest technology investors, with Ontario Teachers' Pension Plan participating for the third consecutive round. Existing shareholders Teachers' Venture Growth and Index Ventures also participated, alongside new investor Dara Holdings. Closing remains subject to regulatory approvals including from the relevant French financial authorities.

Alan's Canadian push is the clearest expression of what the funding is for. Alan received a federal licence from the Office of the Superintendent of Financial Institutions in late 2024, becoming the first new health insurance carrier licensed in Canada since 1957, and is now licensed in every province.

The target market is a concentrated one. Three group benefits carriers — Great-West Life, Sun Life Financial and Manulife Financial — together hold approximately 70% or more of Canada's group benefits market. Alan is positioning its fully digital, prevention-focused model as a challenge to that concentration, arguing the market has seen little meaningful innovation in decades. Member volume in Canada more than tripled since the end of 2025, and the company recently signed its first Canadian group of more than 1,000 members, a sign it is beginning to move upmarket from its initial small-employer base.

A market under cost pressure and structural change

Alan is entering a Canadian group benefits market under considerable strain. Industry forecasters expect extended health benefit cost increases of between 6% and 10% in 2026, driven by specialty drug growth, provider fee pressures and an aging workforce, with mental health claims now representing 35% or more of total claims while accounting for approximately 70% of total costs. 

The pharmacare landscape is adding further complexity for plan sponsors. Canada's federal pharmacare program, which covers diabetes medications and contraceptives in four jurisdictions, appeared to stall in spring 2026 when the government's economic update signaled no new bilateral funding, raising uncertainty over how private employer plans will need to adapt. Private drug plans currently cover approximately 40% to 50% more medications than public plans and provide access to newly approved drugs around 500 days faster, meaning employer-sponsored plans remain the primary route to comprehensive coverage for most working Canadians. 

That environment gives Alan a clear opening. Canadian employers in 2026 are increasingly treating group benefits as a strategic tool for recruitment and retention rather than a compliance obligation, with rising costs driving demand for more data-driven, proactive plan management. Alan's model combines coverage, prevention programs, care navigation and AI-powered health assistance in a single digital platform, aimed at employers looking to shift from cost management to cost prevention. 

Prevention-first model in a competitive digital market

Alan described its proposition as "prevention insurance," a category it claims to have pioneered, integrating health coverage, wellbeing services and AI-powered assistance in one platform. The company plans to accelerate expansion into new countries, deepen its presence in France, Belgium, Spain and Canada, pursue acquisitions and continue investing in AI and healthcare product development.

Its January 2026 Quebec launch used a French-first platform built specifically for the province rather than a translated version of its existing product — a detail that speaks to the operational complexity of competing at scale in Canada's linguistically divided market, and to the deliberateness of Alan's Canadian build.

Company financials

In Q1 2026, Alan reached more than €800 million in annual recurring revenue, grew 53% year on year, surpassed 1.1 million members across its four markets and is profitable in France, its largest and most mature market. The company has now raised more than €1.2 billion in total funding since its founding in 2016.

Jean-Charles Samuelian-Werve, co-founder and CEO of Alan, said: "Health can't wait — not for symptoms to get worse, not for a six-month appointment, not for the system to catch up. Yet that is exactly how the Canadian healthcare system works today. We believe great health is a universal right, and that prevention should be too."

Mark Goad, General Manager of Alan Canada, said: "Canadians are ready to raise their standards for health insurance. Gone are paper forms, slow responses, poor service, and high prices. We've built Alan in Canada around the idea that insurance should keep you in good health. This funding helps us move faster to bring prevention-first coverage to more Canadian employers and their teams."

Related Stories

Keep up with the latest news and events

Join our mailing list, it’s free!